Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer [Phase 2]
This is a Phase II study of radiation therapy combined with paclitaxel poliglumex and carboplatin for stage III non-small cell lung cancer; …
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a tiotropium inhaler to treat shortness of breath in patients with advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Health Related Quality of Life After Video Assisted Thoracoscopic Lobectomy for Lung Cancer
Clinical trial update reporting health-related quality of life after video-assisted thoracoscopic lobectomy for operable early-stage non-sma…
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation [Phase 2]
This update describes a Phase 2 trial evaluating icotinib as adjuvant therapy for patients with EGFR-mutant non-small cell lung cancer.
-
EMA approval · 2015-05-22New treatment option for patients with advanced lung cancer
EMA announces a new treatment option for patients with advanced lung cancer, indicating a regulatory advancement for an additional therapy i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy [Phase 4]
A Phase 4 trial evaluating an increased dose of icotinib in patients with non-small cell lung cancer who previously received gefitinib is cu…
-
CLINICAL_TRIALS research · 2015-05-22Clinical Trial Update: High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease [Phase 2]
A Phase 2 clinical trial compares high-dose versus routine-dose icotinib in patients with advanced non-small cell lung cancer who have stabl…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. [Phase 2]
Phase 2 study of the CDK4/6 inhibitor PD0332991 (palbociclib) in advanced non-small cell lung cancer has been completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial update for ganetespib in ALK-positive non-small cell lung cancer, with the study status listed as completed.
-
CLINICAL_TRIALS research · 2015-05-19Clinical Trial Update: Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)
This completed epidemiological study describes clinical management patterns for non-small cell lung cancer in Central and Eastern Europe and…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Trial of Poor Performance Status Patients (ToPPS) [Phase 2]
Phase 2 trial update (ToPPS) in patients with non-small cell lung cancer and poor performance status. The study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial investigated carboplatin plus gemcitabine in elderly patients with stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC [Phase 2]
Phase 2 trial evaluating adding bevacizumab and erlotinib to carboplatin and docetaxel versus chemotherapy alone in resected non-small cell …
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy [Phase 3]
Phase III trial of Lucanix in advanced non-small cell lung cancer following front-line chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)
This completed observational pilot trial evaluated the feasibility of conducting genome-wide association studies using subject-provided info…
-
CLINICAL_TRIALS withdrawal · 2015-05-08Clinical Trial Update: Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating Tarceva (erlotinib) in combination with AT-101 for advanced non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a dose-escalation study of TH-302 in combination with gemcitabine, docetaxel, or pemetr…
-
CLINICAL_TRIALS other · 2015-05-07Clinical Trial Update: Perioperative Rehabilitation in Operation for Lung Cancer [NA]
The clinical trial NCT01893580 evaluating perioperative rehabilitation for lung cancer surgery was terminated.
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: Comparative Study of Chemoradiation and Sequential Chemoradiation About Lung Adenocarcinoma Patients With Postoperative in pN2 [NA]
Clinical trial update describing a study comparing chemoradiation with sequential chemoradiation in postoperative pN2 lung cancer patients, …
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial update examining EF5 as a biomarker to assess tumor response to anticancer therapy in patients with stage I-III non-small ce…
-
CLINICAL_TRIALS research · 2015-04-30Clinical Trial Update: Chemotherapy of NSCLC With or Without Icotinib [Phase 2]
Phase 2 clinical trial evaluating chemotherapy with vs without the EGFR inhibitor icotinib for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
A terminated clinical trial update studying soluble and cellular biomarkers and functional imaging during antiangiogenic therapies in cancer…
-
CLINICAL_TRIALS research · 2015-04-29Clinical Trial Update: Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma [Phase 4]
A Phase 4 trial is evaluating whether adding sequential chemotherapy to icotinib improves first-line treatment outcomes for stage IIIB/IV EG…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating WST11 in patients with obstructing endobronchial non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2015-04-27Clinical Trial Update: Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating Abraxane with radiation therapy for stage III non-small cell lung cancer has been withdrawn.